Using immunology to transform life-threatening and life-limiting diseases



NovaBiotics’ proprietary technology platforms have been generated through rational drug design principles, using a ‘smart immunology’ approach.  These platforms are based on the body’s own infection-fighting innate immune defense molecules, antimicrobial peptides and aminothiols.  These first responders of the immune system are cornerstones of the body’s defense against infection. The therapy candidates we have developed from our platforms are ‘supercharged’ versions of these natural antimicrobials.


NovaBiotics’ have a number of publications across various platforms.  Please click on the link NovaBiotics publications to see the full list including links to view specific publications of interest.